Bitcoin is down bad, Ren’s portfolio shake-up & Pimp my Portfolio with Matt Ingram
Bitcoin has slid into bear-market territory and we dig into the what's really driving the sell-off. Plus, we also look at a surprising shift in the US: obesity rates are finally dropping, driven by the explosive rise of GLP-1 drugs like Ozempic. What does it mean for stocks like Eli Lilly and Novo Nordisk? That’s not…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Equity Mates Investing Podcast
See all episodes →
61%3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
59%4 investors, $100,000: Who’s winning 6 months in? | Portfolio Challenge
59%AI investors are getting nervous. Should they be?
Similar episodes from other shows
More like Equity Mates Investing Podcast →
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.